UK registered organisations can apply for a share of up to £30 million to develop innovative healthcare products, technologies and processes.
These can include, for example:
Disease prevention and proactive management of health and chronic conditions
earlier and better detection and diagnosis of disease, leading to better patient outcomes
tailored treatments that either change the underlying disease or offer potential cures
This competition combines the early and late stage strands of the Biomedical Catalyst.
This funding is from Innovate UK, part of UK Research and Innovation.
This competition closes at 11am UK time on the deadline stated.
Your project’s total eligible costs must be between £250,000 and £4 million.